List of works - Pamela J Atherton

A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors.

scientific article published in March 2002

A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer

scientific article

A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.

scientific article

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial

scientific article published on 5 May 2017

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors

scientific article published on 19 November 2005

A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer

scientific article published in August 2002

A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin

scientific article published in October 2002

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.

scientific article

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

scientific article

A prospective descriptive study exploring hope, spiritual well-being, and quality of life in hospitalized patients.

scientific article published in August 2008

A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance)

scientific article published on 19 April 2020

Analyzing the "correct" endpoint.

scientific article published in November 2006

Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series

scientific article published on 02 January 2019

Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1

scientific article published on 08 June 2013

Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA.

scientific article

Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial

scientific article published on 9 July 2015

Cancer Caregiver: Perceived Benefits of Technology

scientific article

Cancer caregiver quality of life: need for targeted intervention

scientific article published on 11 September 2015

Caregivers of patients with cancer fatigue: a high level of symptom burden

scientific article

Combining information across symptom studies

scientific article published in November 2005

Combining symptom and survival data

scientific article

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors

scientific article published in March 2002

Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).

scientific article

Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial

article

Dehydroepiandrosterone for the treatment of hot flashes: a pilot study

scientific article published in January 2006

Do age and quality of life of patients with cancer influence quality of life of the caregiver?

scientific article

Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?

scientific article published on 23 April 2013

Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4)

scientific article published on 01 April 2007

Effects of a multidisciplinary quality of life intervention on sleep quality in patients with advanced cancer receiving radiation therapy

scientific article published on 26 September 2019

Effects of a multidisciplinary quality of life intervention on sleep quality in patients with advanced cancer receiving radiation therapy - CORRIGENDUM

scientific article published on 23 October 2019

Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer.

scientific article

Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).

scientific article published on 18 September 2017

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

scientific article published on 16 February 2017

Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.

scientific article

Health related quality of life in patients with Charcot arthropathy of the foot and ankle

scientific article published on 22 October 2007

Impact of a structured multidisciplinary intervention on quality of life of older adults with advanced cancer

scientific article

Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial

scientific article

Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide

scientific article

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial

scientific article published on 01 June 2020

Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254

scientific article published on 12 April 2016

MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

scientific article published on 08 August 2015

Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study

scientific article published on 22 January 2010

Measuring spiritual quality of life in patients with cancer.

scientific article

Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4

scientific article

North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.

scientific article published on June 2015

North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study

scientific article

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

scientific article

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

scientific article published on 27 May 2009

Overall survival and self-reported fatigue in patients with esophageal cancer

scientific article published on 29 July 2012

Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992).

scientific article published on 30 June 2016

Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy

scientific article published on 16 July 2020

Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma

scientific article published on 01 January 2002

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma

scientific article published on 27 September 2018

Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points.

scientific article published on August 2005

Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity

scientific article published on 01 March 2000

Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors

scientific article published on 8 September 2003

Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia

scientific article

Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors

scientific article published on 01 April 2000

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.

scientific article

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

scientific article published on 01 February 2005

Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks

scientific article

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

scientific article

Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).

scientific article

Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

scientific article

Phase II Evaluation of Desipramine for the Treatment of Hot Flashes

scientific article published in September 2007

Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes.

scientific article published on 08 August 2015

Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).

scientific article published on 02 December 2013

Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer

scientific article published on 15 December 2008

Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA

scientific article published on 02 September 2008

Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.

scientific article

Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial

scientific article

Pilot evaluation of aprepitant for the treatment of hot flashes

scientific article published in July 2006

Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. ⬇️

scientific article published on 06 May 2009

Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide

scientific article published on December 2002

Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale.

scientific article

Quality of life of caregivers of patients with advanced-stage cancer

scientific article

Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer

scientific article published on 28 August 2012

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.

scientific article published in May 2007

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).

scientific article published on 14 April 2016

Rising importance of patient-reported outcomes

scientific article published on 01 November 2006

Role of a medical social worker in improving quality of life for patients with advanced cancer with a structured multidisciplinary intervention

scientific article published on January 2007

Spiritual quality of life in advanced cancer patients receiving radiation therapy

scientific article

Spiritual well-being and quality of life of women with ovarian cancer and their spouses

scientific article published on 14 December 2011

Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).

scientific article published on 21 November 2017

The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591).

scientific article

The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.

scientific article published on January 2007

The relation between cancer patient treatment decision-making roles and quality of life

scientific article

The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).

scientific article

Therapeutic exercise during outpatient radiation therapy for advanced cancer: Feasibility and impact on physical well-being

scientific article published in August 2010

Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).

scientific article

Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?

scientific article published in February 2006

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy

scientific article

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up

scientific article published on 23 August 2015

List of works by Pamela J Atherton

A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors.

A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer

A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors

A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer

A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

A prospective descriptive study exploring hope, spiritual well-being, and quality of life in hospitalized patients.

A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance)

Analyzing the "correct" endpoint.

Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series

Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1

Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA.

Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial

Cancer Caregiver: Perceived Benefits of Technology

Cancer caregiver quality of life: need for targeted intervention

Caregivers of patients with cancer fatigue: a high level of symptom burden

Combining information across symptom studies

Combining symptom and survival data

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors

Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).

Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial

Dehydroepiandrosterone for the treatment of hot flashes: a pilot study

Do age and quality of life of patients with cancer influence quality of life of the caregiver?

Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?

Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4)

Effects of a multidisciplinary quality of life intervention on sleep quality in patients with advanced cancer receiving radiation therapy

Effects of a multidisciplinary quality of life intervention on sleep quality in patients with advanced cancer receiving radiation therapy - CORRIGENDUM

Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer.

Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.

Health related quality of life in patients with Charcot arthropathy of the foot and ankle

Impact of a structured multidisciplinary intervention on quality of life of older adults with advanced cancer

Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial

Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial

Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254

MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study

Measuring spiritual quality of life in patients with cancer.

Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4

North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.

North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

Overall survival and self-reported fatigue in patients with esophageal cancer

Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992).

Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy

Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma

Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points.

Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity

Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors

Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia

Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).

Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

Phase II Evaluation of Desipramine for the Treatment of Hot Flashes

Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes.

Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).

Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer

Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA

Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.

Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial

Pilot evaluation of aprepitant for the treatment of hot flashes

Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. ⬇️

Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide

Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale.

Quality of life of caregivers of patients with advanced-stage cancer

Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).